Ipsen Logo

Ipsen

IPN | PA

Overview

Corporate Details

ISIN(s):
FR0010259150 (+17 more)
LEI:
549300M6SGDPB4Z94P11
Country:
France
Address:
65 QUAI GEORGES GORSE, 92100 BOULOGNE-BILLANCOURT
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs for patients. Its core business activities are concentrated in three key therapeutic areas: Oncology, Rare Diseases, and Neuroscience. Ipsen leverages its specialized expertise, global infrastructure, and strategic partnerships to accelerate its research pipeline and bring new therapies to market. The firm's strategy emphasizes advancing science with purpose to improve and extend the lives of people living with complex conditions.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Ipsen. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-02 18:00
Transaction in Own Shares
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - …
French 269.9 KB
2025-09-02 18:00
Transaction in Own Shares
IPSEN - Buy-back programme - Art 5 of MAR - Week 35 - 2025
English 542.0 KB
2025-07-10 18:30
Declaration of Voting Results & Voting Rights Announcements
Ipsen - Juin 2025 - Information mensuelle relative au nombre total des droits d…
French 124.2 KB
2025-07-10 18:30
Declaration of Voting Results & Voting Rights Announcements
Ipsen - June 2025 - Monthly information relative to the total number of voting …
English 106.7 KB
2025-07-01 09:00
Environmental & Social Information
Gemeinsam fur eine bessere Zukunft: Ipsen Pharma GmbH engagiert sich am Communi…
German 8.6 KB
2025-06-17 18:00
Transaction in Own Shares
IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2025
English 271.6 KB
2025-06-17 18:00
Transaction in Own Shares
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - …
English 468.0 KB
2025-06-13 18:00
Transaction in Own Shares
IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025
English 324.3 KB
2025-06-13 18:00
Transaction in Own Shares
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - …
English 293.1 KB
2025-06-12 18:00
Declaration of Voting Results & Voting Rights Announcements
Ipsen - May 2025 - Monthly information relative to the total number of voting r…
English 106.5 KB
2025-06-12 18:00
Declaration of Voting Results & Voting Rights Announcements
Ipsen - Mai 2025 - Information mensuelle relative au nombre total des droits de…
French 145.2 KB
2025-06-10 14:51
Major Shareholding Notification
Franchissement de seuil
French 125.2 KB
2025-06-02 07:00
Transaction in Own Shares
Ipsen S.A. - Initiation of the share buy-back program
English 104.2 KB
2025-06-02 07:00
Transaction in Own Shares
Ipsen S.A. - Lancement du programme de rachat d'actions
French 101.6 KB
2025-05-21 18:00
Post-Annual General Meeting Information
Ipsen S.A. - Assemblée Générale Annuelle du 21 mai 2025
French 102.0 KB

Automate Your Workflow. Get a real-time feed of all Ipsen filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Ipsen via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-09-04 N/A Other Sell 850 91,374.66 EUR
2024-02-27 N/A Other Buy 500 51,916.20 EUR
2023-07-31 N/A Other Buy 50,048 N/A

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK